Bull
$148.27
Scenario price
$97.930
+0.666 (+0.68%)At close
Ingredion Incorporated is a global ingredient solutions provider that transforms grains, fruits, vegetables and other plant-based materials into ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. The Company operates through three segments, which include Texture & Healthful Solutions (T&HS), Food & Industrial Ingredients (F&II)–Latin America (LATAM), and F&II–U.S./Canada. The Texture & Healthful Solutions segment primarily manufactures texturizing food ingredients. The Food & Industrial Ingredients segment primarily manufactures food, ingredient, and industrial products, which are processed from raw materials that primarily source within South America and Mexico. The Food & Industrial Ingredients–United States/Canada segment primarily manufactures food, ingredients, and industrial products. The Company's Benicaros is a patented, prebiotic fiber made from upcycled carrot pomace clinically to support immune health.
Currently, Ingredion Inc is not a strong buy. The stock is priced at $95.09, with a forward P/E of 8.39 indicating it is undervalued compared to the market. However, the RSI is at 39.23, suggesting it is nearing oversold territory, but not yet a clear buy signal. The recent downgrade from UBS lowered the price target to $104, which is only a 9.3% upside from the current price, limiting immediate upside potential. Additionally, the gross margin has decreased to 23.03%, down from 26.02% a year ago, indicating rising cost pressures. The main risk is the declining net income trend, with Q2 2026 net income at $114 million, down from $197 million in Q1 2025, reflecting ongoing challenges in profitability.
UBS
$104
2026-10-05
UBS
2026-10-05
Price Target
$104
Barclays
$118
2026-08-05
Barclays
2026-08-05
Price Target
$118
UBS
$114
2026-05-07
UBS
2026-05-07
Price Target
$114
Barclays
$120
2026-05-06
Barclays
2026-05-06
Price Target
$120
Oppenheimer
$126
2026-04-22
Oppenheimer
2026-04-22
Price Target
$126
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

BJ's Wholesale Surpasses Q2 Earnings Expectations

Ingredion Appoints New CFO to Drive Growth Strategy

Ingredion Reports Q2 2026 Earnings with Strategic Acquisitions and Growth Insights

Ingredion Reports Q2 Decline Amid Acquisition Progress

Ingredion Q2 Earnings Beat Expectations, 2026 Outlook Reaffirmed
Ingredion Incorporated is a global ingredient solutions provider that transforms grains, fruits, vegetables and other plant-based materials into ingredient solutions for the food, beverage, animal nutrition, brewing and industrial markets. The Company operates through three segments, which include Texture & Healthful Solutions (T&HS), Food & Industrial Ingredients (F&II)–Latin America (LATAM), and F&II–U.S./Canada. The Texture & Healthful Solutions segment primarily manufactures texturizing food ingredients. The Food & Industrial Ingredients segment primarily manufactures food, ingredient, and industrial products, which are processed from raw materials that primarily source within South America and Mexico. The Food & Industrial Ingredients–United States/Canada segment primarily manufactures food, ingredients, and industrial products. The Company's Benicaros is a patented, prebiotic fiber made from upcycled carrot pomace clinically to support immune health. It operates in the Consumer Non-Cyclicals sector (GRAIN MILL PRODUCTS industry).
Currently, Ingredion Inc is not a strong buy. The stock is priced at $95.09, with a forward P/E of 8.39 indicating it is undervalued compared to the market. However, the RSI is at 39.23, suggesting it is nearing oversold territory, but not yet a clear buy signal. The recent downgrade from UBS lowered the price target to $104, which is only a 9.3% upside from the current price, limiting immediate upside potential. Additionally, the gross margin has decreased to 23.03%, down from 26.02% a year ago, indicating rising cost pressures. The main risk is the declining net income trend, with Q2 2026 net income at $114 million, down from $197 million in Q1 2025, reflecting ongoing challenges in profitability.
8 analysts cover INGR: 4 rate it Buy, 3 Hold and 1 Sell. The average price target is 125.50.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.